+

WO2007026038A3 - Acide amine de type mycosporine (shinorine) utilise en tant qu'antioxydant - Google Patents

Acide amine de type mycosporine (shinorine) utilise en tant qu'antioxydant Download PDF

Info

Publication number
WO2007026038A3
WO2007026038A3 PCT/ES2006/000492 ES2006000492W WO2007026038A3 WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3 ES 2006000492 W ES2006000492 W ES 2006000492W WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3
Authority
WO
WIPO (PCT)
Prior art keywords
shinorine
mycosporin
amino acid
antioxidant
type amino
Prior art date
Application number
PCT/ES2006/000492
Other languages
English (en)
Spanish (es)
Other versions
WO2007026038A2 (fr
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Original Assignee
Univ Malaga
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaga, La Coba Luque Francisca De, Arjona Jose Aguilera, Figueroa Felix Lopez filed Critical Univ Malaga
Publication of WO2007026038A2 publication Critical patent/WO2007026038A2/fr
Publication of WO2007026038A3 publication Critical patent/WO2007026038A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9733—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne un acide aminé de type mycosporine (shinorine) utilisé en tant qu'antioxydant. L'invention est destinée à être appliquée dans le domaine de la biotechnologie, et décrit l'utilisation potentielle en tant que substance antioxydante d'un acide aminé de type mycosporine (MAA), concrètement de shinorine, isolé à partir de l'algue rouge Gymnogongrus devoniensis, et son éventuelle application dans la préparation d'agents pharmaceutiques, de nutraceutiques, ou d'aliments fonctionnels, entre autres, pour la prévention du stress oxydatif.
PCT/ES2006/000492 2005-08-31 2006-08-28 Acide amine de type mycosporine (shinorine) utilise en tant qu'antioxydant WO2007026038A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200502157 2005-08-31
ES200502157A ES2284344B1 (es) 2005-08-31 2005-08-31 Uso de aminoacido tipo micosporina (shimorine) en productos para prevencion y tratamiento de parkinson y alzheimer.

Publications (2)

Publication Number Publication Date
WO2007026038A2 WO2007026038A2 (fr) 2007-03-08
WO2007026038A3 true WO2007026038A3 (fr) 2007-05-24

Family

ID=37809233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000492 WO2007026038A2 (fr) 2005-08-31 2006-08-28 Acide amine de type mycosporine (shinorine) utilise en tant qu'antioxydant

Country Status (2)

Country Link
ES (5) ES2284344B1 (fr)
WO (1) WO2007026038A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2032122T3 (pl) * 2006-06-27 2016-12-30 Wyciągi z Aphanizomenonu Flos Aquae (AFA Klamath), aktywne związki i ich zastosowania

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (fr) * 1999-12-30 2001-07-06 Gelyma Extrait d'algue a activite filtrante vis a vis des radiations ultraviolettes
WO2002039974A1 (fr) * 2000-11-17 2002-05-23 Natural Environment Research Council Compositions de soins personnels
EP1473028A1 (fr) * 2003-04-30 2004-11-03 Mibelle AG Produits cosmétiques pour le soin de la peau et substances actives pour la protection de la peau contre le vieillissement prématuré

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849346A (ja) * 1981-09-18 1983-03-23 Mitsubishi Chem Ind Ltd マイコスポリン系アミノ酸およびその誘導体
FR2655268B1 (fr) * 1989-12-06 1994-10-14 Secma Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole.
CA2251457A1 (fr) * 1998-10-23 2000-04-23 Norman Huner Compositions comprenant des composes d'origine naturelle tires de plantes, d'algues et de cyanobacteries pour la protection contre les rayons solaires
CA2467102C (fr) * 2001-11-14 2012-07-10 Larena Un produit contenant un extrait d'algue rouge du genre porphyra et ses utilisations pour proteger les cellules
FR2876004B1 (fr) * 2004-10-01 2007-04-06 Exsymol Sa Monegasque Utilisation d'algues rouges soumises a des conditions extremes de temperature et de luminosite
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (fr) * 1999-12-30 2001-07-06 Gelyma Extrait d'algue a activite filtrante vis a vis des radiations ultraviolettes
WO2002039974A1 (fr) * 2000-11-17 2002-05-23 Natural Environment Research Council Compositions de soins personnels
EP1473028A1 (fr) * 2003-04-30 2004-11-03 Mibelle AG Produits cosmétiques pour le soin de la peau et substances actives pour la protection de la peau contre le vieillissement prématuré

Also Published As

Publication number Publication date
ES2301425A1 (es) 2008-06-16
ES2301428B1 (es) 2009-05-01
ES2301426A1 (es) 2008-06-16
ES2301428A1 (es) 2008-06-16
ES2301427A1 (es) 2008-06-16
WO2007026038A2 (fr) 2007-03-08
ES2284344B1 (es) 2008-11-01
ES2301426B1 (es) 2009-05-01
ES2301427B1 (es) 2009-05-01
ES2284344A1 (es) 2007-11-01
ES2301425B1 (es) 2009-05-01

Similar Documents

Publication Publication Date Title
Tantoush et al. Green tea catechins of food supplements facilitate pepsin digestion of major food allergens, but hampers their digestion if oxidized by phenol oxidase
MX2021014701A (es) Extraccion eutectica de solidos.
WO2003041679A3 (fr) Produit contenant un extrait d'algue rouge du genre porphyra
WO2007059715A3 (fr) Methodes et proteines destinees au traitement prophylactique et/ou therapeutique des quatre serotypes du virus de la dengue et autres flavivirus
WO2008036932A3 (fr) Compositions et procédés utilisant l'espèce boswellia
WO2007079139A3 (fr) Formes solides de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoléine-3-carboxamide
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
de Castro et al. Advantages of an acid protease from Aspergillus oryzae over commercial preparations for production of whey protein hydrolysates with antioxidant activities
WO2010130832A3 (fr) Séquences d'acides aminés dirigées contre dickkopf-1 et polypeptides comprenant ces dernières pour le traitement de maladies et de pathologies associées à la déperdition osseuse et/ou à l'ostéolyse
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
IL196133A0 (en) Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
WO2007016591A3 (fr) Compositions et methodes destinees a surveiller et modifier le repliement et la solubilite proteiques
CO2022006972A2 (es) Composiciones que comprenden cepas bacterianas para uso en el aumento de la biodisponibilidad de aminoácidos derivados de proteínas
WO2007053390A3 (fr) Méthodes d'emploi d'acides aminés à chaîne ramifiée
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
WO2009125409A3 (fr) Amides d'acides gras et leurs utilisations
WO2005082927A3 (fr) Peptides utilises contre l'hypertension
JP2011246425A (ja) 大豆蛋白質加水分解物含有抗酸化剤
WO2009064366A3 (fr) Procédés et compositions pour un marquage protéique à l'aide d'acide lipoïque ligases
WO2006042661A3 (fr) Oligopeptides et utilisations
WO2007026035A3 (fr) Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant
WO2007026038A3 (fr) Acide amine de type mycosporine (shinorine) utilise en tant qu'antioxydant
WO2008051448A3 (fr) Procédés et compositions pour l'élimination efficace de la protéine a de préparations de molécules de liaison
WO2005074989A3 (fr) Combinaison (a) d'inhibiteur d'adn topoisomerase et (b) d'inhibiteur de iap
WO2007059047A3 (fr) Acides amines acetyles en tant qu'agents antiplaquettaires, complements nutritifs et vitaminiques

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06807937

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载